SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9053486
Source:
http://linkedlifedata.com/resource/pubmed/id/9053486
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007137
,
umls-concept:C0123931
,
umls-concept:C0282460
,
umls-concept:C0302592
,
umls-concept:C0332152
pubmed:issue
2
pubmed:dateCreated
1997-3-10
pubmed:abstractText
A phase II study was performed to evaluate the antitumor activity and toxicity of irinotecan (CPT-11), a water-soluble derivative of camptothecin, in patients with prior chemotherapy-treated squamous cell cancer of the cervix.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA16672
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic
,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0732-183X
pubmed:author
pubmed-author:EdwardsC LCL
,
pubmed-author:EndeKK
,
pubmed-author:FishmanAA
,
pubmed-author:FreedmanR SRS
,
pubmed-author:HoriJJ
,
pubmed-author:KaplanA LAL
,
pubmed-author:KavanaghJ JJJ
,
pubmed-author:KiebackDD
,
pubmed-author:KudelkaA PAP
,
pubmed-author:LeviDD
,
pubmed-author:LlerenaEE
,
pubmed-author:StegerMM
,
pubmed-author:VerschraegenC FCF
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
625-31
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9053486-Adult
,
pubmed-meshheading:9053486-Antineoplastic Agents, Phytogenic
,
pubmed-meshheading:9053486-Camptothecin
,
pubmed-meshheading:9053486-Carcinoma, Squamous Cell
,
pubmed-meshheading:9053486-Female
,
pubmed-meshheading:9053486-Humans
,
pubmed-meshheading:9053486-Incidence
,
pubmed-meshheading:9053486-Middle Aged
,
pubmed-meshheading:9053486-Survival Analysis
,
pubmed-meshheading:9053486-Treatment Outcome
,
pubmed-meshheading:9053486-Uterine Cervical Neoplasms
pubmed:year
1997
pubmed:articleTitle
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
pubmed:affiliation
University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. cverschr@notes.mdacc.tmc.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Clinical Trial, Phase II